Citation Impact

Citing Papers

XX > XY?: The changing female advantage in life expectancy
2019 StandoutNobel
Prevalence and hazardous impact of pharmaceutical and personal care products and antibiotics in environment: A review on emerging contaminants
2021 Standout
Peroxisomal Dysfunction in Age-Related Diseases
2017
A cohort study on diet and the risk of Parkinson's disease: the role of food groups and diet quality
2012
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women
2012
The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state
2015 Standout
Estrogenic endocrine disruptors: Molecular mechanisms of action
2015
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
G Protein–Coupled Estrogen Receptor Levels After Peripheral Nerve Injury in an Experimental Rat Model
2015
Sex differences in Parkinson’s disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics
2017
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Neuroprotective Effects of Citrus Flavonoids
2012
Citrus peel as a source of functional ingredient: A review
2016 Standout
XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis
2014

Works of Mélanie Bourque being referenced

Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems
2009
Neuroprotective actions of sex steroids in Parkinson’s disease
2009
Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson’s Disease
2011
Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice
2016
Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson’s disease
2012
Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice
2014
Rankless by CCL
2026